Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8 cytotoxic T cells.
作者信息
Heidenreich Falk, Rücker-Braun Elke, Walz Juliane S, Eugster Anne, Kühn Denise, Dietz Sevina, Nelde Annika, Tunger Antje, Wehner Rebekka, Link Cornelia S, Middeke Jan M, Stölzel Friedrich, Tonn Torsten, Stevanovic Stefan, Rammensee Hans-Georg, Bonifacio Ezio, Bachmann Michael, Zeis Matthias, Ehninger Gerhard, Bornhäuser Martin, Schetelig Johannes, Schmitz Marc
机构信息
DKMS German Bone Marrow Donor Center, Clinical Trials Unit, Dresden, Germany
Department of Medicine I, University Hospital of Dresden, Germany.
出版信息
Haematologica. 2017 Nov;102(11):e460-e464. doi: 10.3324/haematol.2017.167312. Epub 2017 Aug 24.
Abstract
摘要
相似文献
1
Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8 cytotoxic T cells.基于质谱法鉴定一种天然呈递的、可被CD8细胞毒性T细胞识别的类受体酪氨酸激酶孤儿受体1衍生表位。
Haematologica. 2017 Nov;102(11):e460-e464. doi: 10.3324/haematol.2017.167312. Epub 2017 Aug 24.
2
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.鉴定具有 CD4+ 和 CD8+ T 细胞表位的混杂 KIF20A 长肽：恶性肿瘤患者中 KIF20A 特异性 CD4+ T 细胞免疫。
Clin Cancer Res. 2013 Aug 15;19(16):4508-20. doi: 10.1158/1078-0432.CCR-13-0197. Epub 2013 May 28.
3
4
Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.急性肝炎中由HLA-B*3501呈递的丙型肝炎病毒细胞毒性T细胞表位的鉴定与表征
J Gen Virol. 1998 Jul;79 ( Pt 7):1735-44. doi: 10.1099/0022-1317-79-7-1735.
5
6
A broad cytotoxic T lymphocyte response to influenza type B virus presented by multiple HLA molecules.针对由多种人类白细胞抗原（HLA）分子呈递的乙型流感病毒的广泛细胞毒性T淋巴细胞反应。
Int Immunol. 1997 Jun;9(6):815-23. doi: 10.1093/intimm/9.6.815.
7
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.癌胚抗原中辅助性T淋巴细胞抗原表位的鉴定
Clin Cancer Res. 2002 Oct;8(10):3219-25.
8
Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.受HLA - B27限制的EBV衍生表位中的免疫显性与EBV转化的B淋巴母细胞系中的表位丰度不相关。
J Immunol. 2000 Jun 15;164(12):6120-9. doi: 10.4049/jimmunol.164.12.6120.
9
TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes.TAP 表达水平在肿瘤细胞中定义了 MHC Ⅰ类肽的性质和加工，用于肿瘤特异性细胞毒性 T 淋巴细胞的识别。
Ann N Y Acad Sci. 2013 Apr;1283:75-80. doi: 10.1111/j.1749-6632.2012.06777.x. Epub 2013 Jan 9.
10
The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes.T细胞受体（TCR）的灵活性使得HIV特异性细胞毒性T淋巴细胞能够识别大量天然存在的表位变体。
Int Immunol. 2001 Jul;13(7):941-50. doi: 10.1093/intimm/13.7.941.
引用本文的文献
1
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8 clonal effector and CAR T-cell function while promoting a senescence-associated phenotype.骨髓间充质基质细胞在阻止 AML 靶向 CD8 克隆效应和 CAR T 细胞功能的同时，促进了衰老相关表型。
Cancer Immunol Immunother. 2024 Jan 17;73(1):8. doi: 10.1007/s00262-023-03594-1.
2
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome.慢性淋巴细胞白血病中的免疫肽组多样性可识别疾病预后良好的患者。
Cancers (Basel). 2022 Sep 25;14(19):4659. doi: 10.3390/cancers14194659.
3
Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens.上游开放阅读框调节与癌症相关的转录本的翻译，并编码 HLA 呈递的免疫原性肿瘤抗原。
Cell Mol Life Sci. 2022 Mar 3;79(3):171. doi: 10.1007/s00018-022-04145-0.
4
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.免疫肽组学指导慢性淋巴细胞白血病基于肽的免疫治疗的仓库设计。
Front Immunol. 2021 Jul 8;12:705974. doi: 10.3389/fimmu.2021.705974. eCollection 2021.
5
Antigen Targets for the Development of Immunotherapies in Leukemia.白血病免疫疗法的抗原靶点。
Int J Mol Sci. 2019 Mar 20;20(6):1397. doi: 10.3390/ijms20061397.
本文引用的文献
1
Driving gene-engineered T cell immunotherapy of cancer.驱动癌症的基因工程T细胞免疫疗法。
Cell Res. 2017 Jan;27(1):38-58. doi: 10.1038/cr.2016.154. Epub 2016 Dec 27.
2
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.人癌组织与正常组织中ROR1蛋白表达分析
Clin Cancer Res. 2017 Jun 15;23(12):3061-3071. doi: 10.1158/1078-0432.CCR-16-2083. Epub 2016 Nov 16.
3
Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology.通过链霉亲和素技术生成具有抗白血病活性的高亲和力、WT1反应性CD8+细胞毒性T细胞克隆。
Leuk Lymphoma. 2017 May;58(5):1246-1249. doi: 10.1080/10428194.2016.1233538. Epub 2016 Nov 16.
4
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia.高水平的ROR1与慢性淋巴细胞白血病的疾病进展加速相关。
Blood. 2016 Dec 22;128(25):2931-2940. doi: 10.1182/blood-2016-04-712562. Epub 2016 Nov 4.
5
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.Wnt5a诱导ROR1/ROR2异源寡聚化以增强白血病的趋化性和增殖。
J Clin Invest. 2016 Feb;126(2):585-98. doi: 10.1172/JCI83535.
6
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.嵌合抗原受体T细胞在复发难治性慢性淋巴细胞白血病中持续存在并诱导持续缓解。
Sci Transl Med. 2015 Sep 2;7(303):303ra139. doi: 10.1126/scitranslmed.aac5415.
7
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).HLA配体组分析确定了慢性淋巴细胞白血病（CLL）中自发抗白血病免疫反应的潜在特异性。
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E166-75. doi: 10.1073/pnas.1416389112. Epub 2014 Dec 29.
8
Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b.基于 TCR 的治疗方法中靶向 BCR 相关蛋白 CD79b 的治疗受到 CD79b 异常表达的阻碍。
Blood. 2015 Feb 5;125(6):949-58. doi: 10.1182/blood-2014-07-587840. Epub 2014 Nov 20.
9
Measuring T cell receptor and T cell gene expression diversity in antigen-responsive human CD4+ T cells.检测抗原反应性人源 CD4+ T 细胞中 T 细胞受体和 T 细胞基因表达的多样性。
J Immunol Methods. 2013 Dec 31;400-401:13-22. doi: 10.1016/j.jim.2013.11.003. Epub 2013 Nov 13.
10
Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.受体酪氨酸激酶 ROR1 在小儿 B 系急性淋巴细胞白血病中的细胞表面表达受限，提示可使用治疗性单克隆抗体进行靶向治疗。
PLoS One. 2012;7(12):e52655. doi: 10.1371/journal.pone.0052655. Epub 2012 Dec 20.
Zotero 插件